Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-Spy 1 TRIAL—CALGB 150007/150012, ACRIN 6657

Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.39.2779

Related search